Reassessing Empirical Use of Vancomycin in Pediatric Patients in Areas with Low MRSA Incidence: A Study of Necessity and Overprescription - Takeaways - MDSpire

Reassessing Empirical Use of Vancomycin in Pediatric Patients in Areas with Low MRSA Incidence: A Study of Necessity and Overprescription

  • By

  • Phuwakrit Nithirungruang

  • Chonnamet Techasaensiri

  • Sophida Boonsathorn

  • Sujittra Chaisavaneeyakorn

  • Nopporn Apiwattanakul

  • January 28, 2026

  • 0 min

Share

  • 1

    Vancomycin is commonly prescribed empirically for pediatric patients with suspected drug-resistant infections, despite low MRSA incidence in some regions.

  • 2

    Overprescription of vancomycin is prevalent, with studies showing a significant percentage of prescriptions not adhering to established guidelines.

  • 3

    In Thailand, the incidence of MRSA was only 8.3% to 9.6% of S. aureus isolates, questioning the justification for empirical vancomycin use.

  • 4

    The study aimed to assess the necessity of empirical vancomycin treatment in pediatric patients and identify factors for appropriate prescribing.

  • 5

    Understanding the factors associated with the need for definitive vancomycin therapy could help reduce overuse and minimize resistance.

Original Source(s)

Reassessing Empirical Use of Vancomycin in Pediatric Patients in Areas with Low MRSA Incidence: A Study of Necessity and Overprescription

  • by Phuwakrit Nithirungruang, Chonnamet Techasaensiri, Sophida Boonsathorn, Sujittra Chaisavaneeyakorn, Nopporn Apiwattanakul

  • January 28, 2026

Related Content

Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus

Disseminated cystic echinococcosis presenting as orbital swelling in a child — case report and literature review

Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs